Chemours Co (CC) : Gmt Capital Corp reduced its stake in Chemours Co by 3.62% during the most recent quarter end. The investment management company now holds a total of 8,509,668 shares of Chemours Co which is valued at $99,903,502 after selling 319,962 shares in Chemours Co , the firm said in a disclosure report filed with the SEC on Aug 8, 2016.Chemours Co makes up approximately 2.23% of Gmt Capital Corp’s portfolio.
Other Hedge Funds, Including , Central Trust Co reduced its stake in CC by selling 855 shares or 30.79% in the most recent quarter. The Hedge Fund company now holds 1,922 shares of CC which is valued at $22,564.Cable Hill Partners reduced its stake in CC by selling 28 shares or 41.18% in the most recent quarter. The Hedge Fund company now holds 40 shares of CC which is valued at $364.Seaward Management Limited Partnership boosted its stake in CC in the latest quarter, The investment management firm added 1,765 additional shares and now holds a total of 12,568 shares of Chemours Co which is valued at $119,396. Chemours Co makes up approx 0.01% of Seaward Management Limited Partnership’s portfolio.Winslow Evans Crocker reduced its stake in CC by selling 99 shares or 10.61% in the most recent quarter. The Hedge Fund company now holds 834 shares of CC which is valued at $7,373.Heritage Investors Management Corp reduced its stake in CC by selling 2,861 shares or 1.6% in the most recent quarter. The Hedge Fund company now holds 175,959 shares of CC which is valued at $1,645,217. Chemours Co makes up approx 0.12% of Heritage Investors Management Corp’s portfolio.
Chemours Co opened for trading at $11.48 and hit $12.45 on the upside on Monday, eventually ending the session at $12.25, with a gain of 7.27% or 0.83 points. The heightened volatility saw the trading volume jump to 40,65,749 shares. Company has a market cap of $2,224 M.
On the company’s financial health, Chemours Co reported $0.27 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.17. The company had revenue of $1383.00 million for the quarter, compared to analysts expectations of $1418.96 million. The company’s revenue was down -8.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.10 EPS.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.